SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001571049-18-000485
Filing Date
2018-09-24
Accepted
2018-09-21 17:48:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 FINAL PROSPECTUS tv503197-424b5.htm 424B5 505985
2 GRAPHIC lg_titan-pharma.jpg GRAPHIC 53272
  Complete submission text file 0001571049-18-000485.txt   578478
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-226841 | Film No.: 181082323
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1